Publicacions en col·laboració amb investigadors/es de Hospital de Mataró (2)

2009

  1. A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/ emtricitabine in HIV-1-infected patients with virological suppression

    Journal of Acquired Immune Deficiency Syndromes, Vol. 51, Núm. 3, pp. 290-297

  2. Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor - sparing strategy: Results from the multicenter study with nevirapine and kaletra (MULTTNEKA)

    Clinical Infectious Diseases, Vol. 49, Núm. 6, pp. 892-900